Related Experiment Video
Updated: Jun 22, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Soft tissue infections
Karina D Torralba1, Francisco P Quismorio
1Division of Rheumatology, Department of Internal Medicine, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 711, Los Angeles, CA 90033, USA. ktorrabl@usc.edu
Abstract:
Soft tissue infections are common and potentially fatal conditions. Infections are a major cause of morbidity and mortality in patients who have rheumatic disease. Patients who have rheumatic diseases may be at increased risk for soft tissue infections because of various factors, including inherent immunologic defects, genetics, and use of immunomodulatory therapy, including biologic agents. Timely diagnosis and management with the institution of antibiotics with or without surgical intervention is imperative for effective resolution of infection. This article provides a review of recent literature on the presentation and clinical course of infectious tenosynovitis, septic bursitis, pyomyositis, and necrotizing fasciitis, especially in relation to patients who have rheumatic disease.
Insights
Patients with rheumatic diseases face higher risks of potentially fatal soft tissue infections. Prompt diagnosis and treatment, including antibiotics and surgery, are crucial for managing these infections.
Area of Science:
- Infectious diseases
- Rheumatology
- Immunology
Background:
- Soft tissue infections pose significant morbidity and mortality risks, particularly in individuals with rheumatic diseases.
- Rheumatic disease patients may have increased susceptibility due to immunologic defects, genetic factors, and immunomodulatory therapies like biologic agents.
- Effective management necessitates prompt diagnosis and intervention with antibiotics and potentially surgical procedures.
Purpose of the Study:
- To review recent literature on soft tissue infections in patients with rheumatic diseases.
- To examine the presentation and clinical course of specific infections including infectious tenosynovitis, septic bursitis, pyomyositis, and necrotizing fasciitis.
- To highlight the unique considerations for managing these infections in the context of rheumatic conditions.
Main Methods:
- Literature review of recent publications.
- Analysis of clinical presentations and disease progression.
- Focus on infectious tenosynovitis, septic bursitis, pyomyositis, and necrotizing fasciitis.
Main Results:
- Soft tissue infections are common and life-threatening in rheumatic disease patients.
- Immunomodulatory therapies, including biologics, may increase infection risk.
- Timely diagnosis and treatment are essential for favorable outcomes.
Conclusions:
- Rheumatic disease patients require vigilant monitoring for soft tissue infections.
- Understanding the specific risks and presentations is key for effective management.
- Integrated approaches involving antibiotics and surgery are vital for resolving these infections.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Staphylococcal Skin Infections
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Endocarditis I: Introduction
Healing II: Complications
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...